Aaron Kesselheim co-authors and is in the news

Aaron Kesselheim (2009 Awardee) authors "Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy" in The Journal of American Medical Association, 316(22) pp. 2357-2358, December 13, 2016 in "Congress Just Quietly Handed Drug Companies a Dangerous Victory", December 14, 2016 and in "Obama, paying tribute to Biden and bipartisanship, signs 21st Century Cures Act Tuesday" in The Washington Post, December 13, 2016.

News Source: 
Tuesday, December 13, 2016